Determines the proportion of patients with esophageal cancer who displayed isolated tumor cells in their bone marrow. Development of monoclonal antibodies (MAb) directed against epithelial cell-associated and tumor antigens; Presence of tumor cells in the bone marrow as an indicator of the disseminatory potential of individual tumors.